Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Spontaneous Oral-Facial Dyskinesia

Spontaneous Oral-Facial Dyskinesia Abstract Oral-facial dyskinesia is not uncommonly encountered as side-effect of chronic phenothiazine treatment or levodopa therapy, is less commonly seen during the course of known hereditary or acquired basal ganglia diseases, and is rarely seen under other circumstances. Two cases of spontaneous oral-facial dyskinesia are described. The pathology and pathophysiology of this type of involuntary movement disorder are unknown, and the prognosis is uncertain. No effective treatment is yet available. References 1. Schonecker M: Ein eigentumliches Syndrom im ovalen Bereich bei Megaphen Applikation . Nervenarzt 28:35-42, 1957. 2. Sigwald J, Bouttier D, Raymondeaud C, et al: Quatre cas de dyskinésie facio-bucco-linguo-masticatrice á èvolution prolongée secondaire á un traitment par les neuroleptiques . Rev Neurol 100:751-755, 1959. 3. Druckman R, Seelinger D, Thulin B: Chronic involuntary movements induced by phenothiazines . J Nerv Ment Dis 135:69-76, 1962.Crossref 4. Faurbye A, Rasch PJ, Petersen PB, et al: Neurological symptoms in pharmacotherapy of psychoses . Acta Psychiat Scand 40:10-27, 1964.Crossref 5. Hunter R, Earl CJ, Thornicroft S: An apparently irreversible syndrome of abnormal movements following phenothiazine medication . Proc Roy Soc Med 57:758-762, 1964. 6. Schmidt WR, Jarcho LW: Persistent dyskinesias following phenothiazine therapy: Report of five cases and a review of the literature . Arch Neurol 14:369-377, 1966.Crossref 7. Siede H, Müller HF: Choreiform movements as side effects of phenothiazine medication in geriatric patients . J Amer Geriat Soc 15:517-522, 1967. 8. Crane GE: Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature . Amer J Psychiat 124( (suppl) ):40-48, 1968. 9. Heinrich K, Wegener I, Bender HJ: Spate Extrapyramidale hyperkinesen bei Neuroleptischer Langzeittherapie . Pharmakopsychiat Neuropsychopharm 1:169-195, 1968.Crossref 10. Crane GE: High Doses of trifluperazine and tardive dyskinesia . Arch Neurol 22:176-180, 1970.Crossref 11. Yahr MD, Duvoisin RC, Schear MJ, et al: Treatment of parkinsonism with levodopa . Arch Neurol 21:343-354, 1969.Crossref 12. Bruyn GW: Huntington's chorea , in Vinken PJ, Bruyn GW (eds): Diseases of the Basal Ganglia . New York, Elsevier Publishing Co, 1968. 13. Thiebaut F: Sydenham's chorea , Vinken PJ, Bruyn GW (eds): Diseases of the Basal Ganglia . New York, Elsevier Publishing Co, 1968. 14. Degwitz R: Extrapyramidal motor disorders following long-term treatment with neuroleptic drugs , in Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969. 15. Marie P, Levy G: Le Syndrome Excito-Moteur de L'Encephalite Epidemique . Rev Neurol 36:513-536, 1920. 16. Stern F: Die Epidemische Encephalitis . Berlin, Springer Verlag, 1922. 17. Sutcher HD, Underwood RB, Beatty RA, et al: Orofacial dyskinesia a dental dimension . JAMA 216:1459-1463, 1971.Crossref 18. Appenzeller O, Biehl JP: Mouthing in the elderly: A cerebellar sign . J Neurol Sci 6:249-260, 1968.Crossref 19. Greenhouse AH: On chorea, lupus erythematous, and cerebral arteritis . Arch Intern Med 117:389-393, 1966.Crossref 20. Hurwitz LJ, Montgomery DAO: Persistent choreo-athetotic movements in liver disease . Arch Neurol 13:421-426, 1965.Crossref 21. Van Bogaert L: Syndrome extrapyramidal au cours d'une maladie de Pick . J Belg Neurol Psychiat 34:315-320, 1934. 22. Greenblatt L, Dominick JR, Stotsky BA, et al: Phenothiazine-induced dyskinesia in nursinghome patients . J Amer Geriat Soc 16:27-34, 1968. 23. Delay J, Deniker P, Dalle B, et al: Syndrome choreique idiopathique rappelant la sémiologie d' imprégnation chronique par les neuroleptiques . Ann Medicopsych 125:784-788, 1967. 24. Paulson GW: An evaluation of the permanence of the "tardive dyskinesias." Dis Nerv Syst 29:692-694, 1968. 25. Degwitz R: in discussion, Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 32. 26. Baker AB: in discussion, Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 29, 44. 27. Demars J: Neuromuscular effects of longterm phenothiazine medication, electroconvulsive therapy and leucotomy . J Nerv Ment Dis 143:73-79, 1966.Crossref 28. Melvin KEW: Tetanus-like reactions of the phenothiazine drugs, "The Grimacing Syndrome." New Zeal Med J 61:90-92, 1962. 29. Carpenter MB: Brain stem nuclei in studies of experimental dyskinesia . J Neurosurg 24( (suppl) ): 185-190, 1966. 30. Hughes B: Involuntary movements following stereotaxic operations for parkinsonism with special reference to hemichorea (ballismus) . J Neurol Neurosurg Psychiat 28:291-303, 1965.Crossref 31. Van Buren JM: in discussion, Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 169. 32. Papavasiliou P: in discussion, Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 145. 33. Dill RE, Nickey WM, Little MD: Dyskinesias in rats following chemical stimulation of the neostriatum . Texas Rep Biol Med 26:101-106, 1968. 34. Nashold BS, Slaughter DG: Effects of stimulating or destroying deep cerebellar regions in man . J Neurosurg 31:172-186, 1969.Crossref 35. Nashold BS: The effects of central tegmental lesions on tardive dyskinesia , in Degwitz R: Psychotropic Drugs and Dsyfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969. 36. Christensen E, Moller JE, Faurbye A: Neuropathological investigation of 28 brains from patients with dyskinesia . Acta Psychiat Scand 46:14-23, 1970.Crossref 37. Cammermeyer, J: Neuropathological study of rhesus chronically treated with chlorpromazine , in Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, pp 19-20. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Neurology American Medical Association

Spontaneous Oral-Facial Dyskinesia

Archives of Neurology , Volume 26 (6) – Jun 1, 1972

Loading next page...
 
/lp/american-medical-association/spontaneous-oral-facial-dyskinesia-Jd7gnL0LvP

References (33)

Publisher
American Medical Association
Copyright
Copyright © 1972 American Medical Association. All Rights Reserved.
ISSN
0003-9942
eISSN
1538-3687
DOI
10.1001/archneur.1972.00490120046004
Publisher site
See Article on Publisher Site

Abstract

Abstract Oral-facial dyskinesia is not uncommonly encountered as side-effect of chronic phenothiazine treatment or levodopa therapy, is less commonly seen during the course of known hereditary or acquired basal ganglia diseases, and is rarely seen under other circumstances. Two cases of spontaneous oral-facial dyskinesia are described. The pathology and pathophysiology of this type of involuntary movement disorder are unknown, and the prognosis is uncertain. No effective treatment is yet available. References 1. Schonecker M: Ein eigentumliches Syndrom im ovalen Bereich bei Megaphen Applikation . Nervenarzt 28:35-42, 1957. 2. Sigwald J, Bouttier D, Raymondeaud C, et al: Quatre cas de dyskinésie facio-bucco-linguo-masticatrice á èvolution prolongée secondaire á un traitment par les neuroleptiques . Rev Neurol 100:751-755, 1959. 3. Druckman R, Seelinger D, Thulin B: Chronic involuntary movements induced by phenothiazines . J Nerv Ment Dis 135:69-76, 1962.Crossref 4. Faurbye A, Rasch PJ, Petersen PB, et al: Neurological symptoms in pharmacotherapy of psychoses . Acta Psychiat Scand 40:10-27, 1964.Crossref 5. Hunter R, Earl CJ, Thornicroft S: An apparently irreversible syndrome of abnormal movements following phenothiazine medication . Proc Roy Soc Med 57:758-762, 1964. 6. Schmidt WR, Jarcho LW: Persistent dyskinesias following phenothiazine therapy: Report of five cases and a review of the literature . Arch Neurol 14:369-377, 1966.Crossref 7. Siede H, Müller HF: Choreiform movements as side effects of phenothiazine medication in geriatric patients . J Amer Geriat Soc 15:517-522, 1967. 8. Crane GE: Tardive dyskinesia in patients treated with major neuroleptics: A review of the literature . Amer J Psychiat 124( (suppl) ):40-48, 1968. 9. Heinrich K, Wegener I, Bender HJ: Spate Extrapyramidale hyperkinesen bei Neuroleptischer Langzeittherapie . Pharmakopsychiat Neuropsychopharm 1:169-195, 1968.Crossref 10. Crane GE: High Doses of trifluperazine and tardive dyskinesia . Arch Neurol 22:176-180, 1970.Crossref 11. Yahr MD, Duvoisin RC, Schear MJ, et al: Treatment of parkinsonism with levodopa . Arch Neurol 21:343-354, 1969.Crossref 12. Bruyn GW: Huntington's chorea , in Vinken PJ, Bruyn GW (eds): Diseases of the Basal Ganglia . New York, Elsevier Publishing Co, 1968. 13. Thiebaut F: Sydenham's chorea , Vinken PJ, Bruyn GW (eds): Diseases of the Basal Ganglia . New York, Elsevier Publishing Co, 1968. 14. Degwitz R: Extrapyramidal motor disorders following long-term treatment with neuroleptic drugs , in Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969. 15. Marie P, Levy G: Le Syndrome Excito-Moteur de L'Encephalite Epidemique . Rev Neurol 36:513-536, 1920. 16. Stern F: Die Epidemische Encephalitis . Berlin, Springer Verlag, 1922. 17. Sutcher HD, Underwood RB, Beatty RA, et al: Orofacial dyskinesia a dental dimension . JAMA 216:1459-1463, 1971.Crossref 18. Appenzeller O, Biehl JP: Mouthing in the elderly: A cerebellar sign . J Neurol Sci 6:249-260, 1968.Crossref 19. Greenhouse AH: On chorea, lupus erythematous, and cerebral arteritis . Arch Intern Med 117:389-393, 1966.Crossref 20. Hurwitz LJ, Montgomery DAO: Persistent choreo-athetotic movements in liver disease . Arch Neurol 13:421-426, 1965.Crossref 21. Van Bogaert L: Syndrome extrapyramidal au cours d'une maladie de Pick . J Belg Neurol Psychiat 34:315-320, 1934. 22. Greenblatt L, Dominick JR, Stotsky BA, et al: Phenothiazine-induced dyskinesia in nursinghome patients . J Amer Geriat Soc 16:27-34, 1968. 23. Delay J, Deniker P, Dalle B, et al: Syndrome choreique idiopathique rappelant la sémiologie d' imprégnation chronique par les neuroleptiques . Ann Medicopsych 125:784-788, 1967. 24. Paulson GW: An evaluation of the permanence of the "tardive dyskinesias." Dis Nerv Syst 29:692-694, 1968. 25. Degwitz R: in discussion, Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 32. 26. Baker AB: in discussion, Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 29, 44. 27. Demars J: Neuromuscular effects of longterm phenothiazine medication, electroconvulsive therapy and leucotomy . J Nerv Ment Dis 143:73-79, 1966.Crossref 28. Melvin KEW: Tetanus-like reactions of the phenothiazine drugs, "The Grimacing Syndrome." New Zeal Med J 61:90-92, 1962. 29. Carpenter MB: Brain stem nuclei in studies of experimental dyskinesia . J Neurosurg 24( (suppl) ): 185-190, 1966. 30. Hughes B: Involuntary movements following stereotaxic operations for parkinsonism with special reference to hemichorea (ballismus) . J Neurol Neurosurg Psychiat 28:291-303, 1965.Crossref 31. Van Buren JM: in discussion, Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 169. 32. Papavasiliou P: in discussion, Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, p 145. 33. Dill RE, Nickey WM, Little MD: Dyskinesias in rats following chemical stimulation of the neostriatum . Texas Rep Biol Med 26:101-106, 1968. 34. Nashold BS, Slaughter DG: Effects of stimulating or destroying deep cerebellar regions in man . J Neurosurg 31:172-186, 1969.Crossref 35. Nashold BS: The effects of central tegmental lesions on tardive dyskinesia , in Degwitz R: Psychotropic Drugs and Dsyfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969. 36. Christensen E, Moller JE, Faurbye A: Neuropathological investigation of 28 brains from patients with dyskinesia . Acta Psychiat Scand 46:14-23, 1970.Crossref 37. Cammermeyer, J: Neuropathological study of rhesus chronically treated with chlorpromazine , in Degwitz R: Psychotropic Drugs and Dysfunctions of the Basal Ganglia , bulletin 1938, Public Health Service, 1969, pp 19-20.

Journal

Archives of NeurologyAmerican Medical Association

Published: Jun 1, 1972

There are no references for this article.